MYXOID LIPOSARCOMA
Clinical trials for MYXOID LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new MYXOID LIPOSARCOMA trials appear
Sign up with your email to follow new studies for MYXOID LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early trial tests novel cancer vaccine injection
Disease control OngoingThis early-stage study is testing the safety of a new experimental cancer vaccine called PeptiCRAd-1 when given alongside the immunotherapy drug pembrolizumab. The trial involves 15 adults with various advanced solid tumors that have specific markers. Researchers will inject the …
Matched conditions: MYXOID LIPOSARCOMA
Phase: PHASE1 • Sponsor: Valo Therapeutics Oy • Aim: Disease control
Last updated Apr 04, 2026 00:05 UTC
-
Experimental immune therapy targets Tough-to-Treat sarcomas
Disease control OngoingThis study is testing whether a personalized immune cell therapy can help control advanced synovial sarcoma or myxoid liposarcoma. Doctors take a patient's own immune cells, genetically modify them to recognize cancer, and infuse them back. The trial will measure how well tumors …
Matched conditions: MYXOID LIPOSARCOMA
Phase: PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC